Medicamen Biotech Limited (NSE:MEDICAMEQ)

Medicamen Biotech Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	2,061	1,978	1,675	1,793	1,409	1,154
Revenue Growth	22.21%	18.04%	-6.56%	27.29%	22.02%	2.42%
Gross Profit Gross Profit Growth	1,059	932.54	810.61	852.01	674.19	612.38
Operating Income Operating Income Growth	155.98	123.69	117.92	152.57	176.32	178.96
Net Income Net Income Growth	96.07	96.41	71.08	109.31	148.44	148.98
Earnings Per Share EPS Growth	7.45	7.11	5.59	8.63	11.73	12.19
EPS Growth	12.21%	27.15%	-35.25%	-26.41%	-3.78%	22.82%

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	312.64	312.64	37.59	147.86	207.79	38.25
Total Debt Total Debt Growth	477.84	491.97	337.74	311.12	257.09	257.96
Net Cash (Debt) Net Cash Growth	-165.19	-179.32	-300.15	-163.26	-49.3	-219.71
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-12.81	-13.22	-23.61	-12.90	-3.90	-17.98

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	-331.72	-81.59	-67.44	-62.93	41.09
Capital Expenditures CapEx Growth	-	-47.78	-21.89	-62.87	-66.01	-86.08
Free Cash Flow Free Cash Flow Growth	-	-379.5	-103.47	-130.31	-128.94	-44.99
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	51.40%	47.15%	48.38%	47.52%	47.86%	53.04%
Operating Margin	7.57%	6.25%	7.04%	8.51%	12.52%	15.50%
Pretax Margin	6.03%	6.06%	5.90%	7.29%	12.10%	15.67%
Profit Margin	4.66%	4.88%	4.24%	6.10%	10.54%	12.90%
FCF Margin	-	-19.19%	-6.18%	-7.27%	-9.15%	-3.90%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 24, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	1.000	1.000	1.000	1.000	1.000	1.000
Dividend Per Share Growth	0%	0%	0%	0%	0%	0%
Dividend Yield	0.32%	0.45%	0.21%	0.26%	0.15%	0.16%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 24, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	45.73	29.63	86.16	44.56	55.87	52.79
PS Ratio	2.13	1.44	3.66	2.72	5.89	6.81

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 20, 2026

Data Sources Report a data error